The Firm is representing Sunrise Medical, Inc. and Vestar Capital Partners in connection with the announced definitive agreement to sell Sunrise Medical’s global mobility and seating operations to funds advised by Equistone Partners Europe. The terms of the purchase of Sunrise Medical from affiliates of Vestar were not disclosed. Vestar had acquired Sunrise Medical, in partnership with Park Avenue Equity Partners, in a going private transaction in 2000. The transaction is expected to close at the end of 2012 and is subject to approval by antitrust authorities.
Sunrise Medical is the leading global manufacturing, marketer and distributor of high-end custom manual and power wheelchairs and technologically advanced and proprietary seating systems. Equistone is one of Europe’s leading investors in mid-market buyouts.
The Simpson Thacher team included Peter Gordon, Kevin Lehpamer and Bianca Bowen (M&A); Marissa Wesely, Mary Touchstone and Mark Maher (Credit); Gary Mandel, Jason Vollbracht and Adam Wells (Tax); Lori Lesser and Danielle Kantor (Intellectual Property); Aimee Adler (Executive Compensation and Employee Benefits); and Michael Naughton (Antitrust).
